Article

Musculoskeletal Pain Outcomes Predicted by Generic Factors as Well as Location

Generic factors-such as pain intensity, levels of disability, and psychological factors-appear to play an important role in the prognosis of acute and chronic nonspinal musculoskeletal pain.

Generic factors-such as pain intensity, levels of disability, and psychological factors-appear to play an important role in the prognosis of acute and chronic nonspinal musculoskeletal pain. This is regardless of the location of pain.

Henschke and associates used data from a prospective observational cohort of primary care patients with acute or chronic nonspinal musculoskeletal pain to develop predictive models. They carried out the analysis in 3 steps: derivation of predictive models, including generic factors only; investigation of the added predictive value of pain location; and investigation of effect modification by pain location.

Generic factors predicted outcome over different time periods (3 months and 12 months) and for both acute and chronic musculoskeletal pain. The most consistent predictors of poor outcome were having had the same complaint in the previous year, a lower level of education, lower scores on the Short Form 36 vitality subscale, using pain medication at baseline, and being bothered by the complaint more often in the past 3 months.

The authors noted that pain location variables only slightly improved the predictive ability of the models over generic factors and were inconsistent across the models.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.